Vivimed Labs Ltd
NSE:VIVIMEDLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Vivimed Labs Ltd
Free Cash Flow
Vivimed Labs Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Vivimed Labs Ltd
NSE:VIVIMEDLAB
|
Free Cash Flow
-₹261.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Free Cash Flow
₹18.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Free Cash Flow
₹27B
|
CAGR 3-Years
10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Free Cash Flow
₹89B
|
CAGR 3-Years
53%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Free Cash Flow
₹29.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Free Cash Flow
₹13.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Vivimed Labs Ltd
Glance View
Vivimed Labs Ltd. engages in the manufacture and market of active ingredients, which are used in home and personal care products and industrial care products. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2005-08-13. The company operates in two segments: Specialty Chemicals Business and Pharma Business. The company serves various companies through the contract manufacturing (CMO) division, which offers a range of products, such as capsules and tablets, syrups and liquids, and nasal sprays and ointments. The active ingredients manufactured by the Company are used in home and personal care segments, such as hair, skin, oral care and anti-microbial preservatives. Its products include DICLOFENAC GEL BP, LULICONAZOLE CREAM, PERMETHRIN LOTION, and CLOTRIMAZOLE VAGINAL GEL. Its subsidiaries include Finoso Pharma Private Limited, Vivimed Specialty Chemicals Private Limited, Vivimed Holdings Limited, and Vivimed Labs USA INC.
See Also
What is Vivimed Labs Ltd's Free Cash Flow?
Free Cash Flow
-261.1m
INR
Based on the financial report for Sep 30, 2025, Vivimed Labs Ltd's Free Cash Flow amounts to -261.1m INR.
What is Vivimed Labs Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 1Y
75%
Over the last year, the Free Cash Flow growth was 75%.
